ZK245186

· Bayer

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ZK245186, covering 2016-01-21 to 2016-01-21. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Different Concentrations of ZK245186 in Atopic Dermatitis (AD) [Phase 2]